Illumina Wins Virtual Cell Challenge, Powered by Billion Cell Atlas
Illumina Wins Virtual Cell Challenge, Powered by Billion Cell Atlas
PR Newswire
SAN DIEGO, Nov. 19, 2026
The unique biological dataset combined with a new CellularAI algorithm wins Illumina a first-place finish in the 2026 Virtual Cell Challenge, hosted by Arc Institute
SAN DIEGO, Nov. 19, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its BioInsight AI Lab won the 2026 Virtual Cell Challenge, hosted by Arc Institute. The company's results were powered by data from Illumina's Billion Cell Atlas and a new cellular response prediction algorithm, CellularAI, which produced highly accurate predictions of cellular responses to genetic perturbations in unseen cell types. The first-place performance underscores how unique, large-scale data and AI innovation can unlock biological discovery and is part of the company's ambition to build leading virtual cell models for understanding biology.
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

5 Stocks to Buy After Earnings

The 10 Best Dividend Stocks

7 Undervalued Stocks That Crushed Earnings

2 5-Star Stocks to Buy at Big Discounts

